Marginal Zone B Cells Support Donor-Specific Alloantibody Responses to Heart Allografts
Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
Meeting: 2021 American Transplant Congress
Abstract number: 210
Keywords: IgG, MHC class I, MHC class II, Mice
Session Information
Session Name: B cell/Antibody and Histocompatibility
Session Type: Rapid Fire Oral Abstract
Date: Monday, June 7, 2021
Session Time: 4:30pm-5:30pm
Presentation Time: 4:35pm-4:40pm
Location: Virtual
*Purpose: Production of high affinity isotype-switched donor specific alloantibodies (DSA) after transplantation is associated with germinal center formation by follicular (FO) B cells whereas the contribution of marginal zone (MZ) B cells is poorly understood. The goal of our study was to test the role of MZ B cells during alloimmune responses.
*Methods: To evaluate MZ B cell responses after transplantation, B6.Blimp-1 (H-2b) reporter mice were transplanted with BALB/c (H-2d) heart allografts. To test MZ B cells contribution to DSA production we treated B6.WT recipients of BALB/c heart allografts with anti-mCD20 18B12 IgG1 mAb that depletes >95% splenic FO but only 40-60% MZ B cells. Serum levels of class I and class II-reactive IgG and IgM DSA were determined by ELISA. We used S1PR1 signaling inhibitor FTY720 to prevent MZ B cells from returning to MZ area. To specifically test the role of MZ B cells in DSA production we used CD19CreNotch2fl/fl mice (ΔMZB) with defective development of MZ B cells as heart allograft recipients. In addition, sera collected fromΔMZB recipients and littermate controls on d.14 posttransplant was transferred to RAG1-/- recipients of BALB/c heart allograft
*Results: Blimp1+ MZ B cells in recipient spleen peaked at d. 7 and declined by d. 14 posttransplant, suggesting their differentiation into early antibody secreting cells. Preferential FO B cell depletion reduced serum IgG DSA levels only at later time points (d. 14 and d. 21), indicating that early IgG DSA are produced by residual MZ B cells. CD4 T cells depletion prior to transplantation showed that these early MZ B cell responses were critically dependent on T cell help. Treatment of heart allograft recipients with FTY720 displaced MZ B cells from spleen MZ area and markedly impaired both class I and class II DSA generation. IgG and IgM DSA generation in ΔMZB recipients was significantly impaired compared to control littermates, even though the priming of donor-reactive IFNγ producing T cells was similar between groups. Transfer of littermate but not ΔMZB sera collected on d.14 posttransplant to RAG1-/- BALB/c heart allograft recipients induced C4d complement deposition, indicating that MZ B cells are required to generate high levels of complement-activating DSA.
*Conclusions: Our findings are the first demonstration for the role of MZ B cells in humoral alloimmune responses following solid organ transplantation and identify MZ B cells as a potential therapeutic target for minimizing de novo DSA production and antibody-mediated rejection in transplant recipients.
To cite this abstract in AMA style:
Gorbacheva V, Fan R, Baldwin W, Fairchild R, Valujskikh A. Marginal Zone B Cells Support Donor-Specific Alloantibody Responses to Heart Allografts [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/marginal-zone-b-cells-support-donor-specific-alloantibody-responses-to-heart-allografts-2/. Accessed November 21, 2024.« Back to 2021 American Transplant Congress